Related Experiment Video
Updated: Mar 24, 2026

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
GRIN1 Mutations in Early-Onset Epileptic Encephalopathy
1Department of Pharmacology, Emory University, Atlanta, GA.
Mutations in the N-methyl-D-aspartate (NMDA) receptor subunit GRIN1 (GluN1) were identified in patients with intellectual disability and epilepsy. This finding sheds light on the genetic causes of these neurological disorders.
Area of Science:
- Neuroscience
- Genetics
- Medical Research
Background:
- N-methyl-D-aspartate (NMDA) receptors are crucial for synaptic plasticity and neuronal function.
- Mutations in NMDA receptor subunits have been implicated in various neurological disorders.
- Intellectual disability and epileptic encephalopathy are complex neurodevelopmental conditions with diverse genetic etiologies.
Purpose of the Study:
- To investigate the role of GRIN1 (GluN1) subunit mutations in patients with nonsyndromic intellectual disability and early-onset epileptic encephalopathy.
Main Methods:
- Genetic analysis of patients with nonsyndromic intellectual disability and early-onset epileptic encephalopathy.
- Identification and characterization of mutations in the GRIN1 gene.
Main Results:
- Mutations in the GRIN1 (GluN1) subunit of NMDA receptors were identified in affected patients.
- These mutations are associated with nonsyndromic intellectual disability and early-onset epileptic encephalopathy.
Conclusions:
- GRIN1 mutations represent a potential genetic cause for nonsyndromic intellectual disability and early-onset epileptic encephalopathy.
- Understanding these mutations can contribute to improved diagnosis and potential therapeutic strategies for these conditions.
More Related Videos
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...